First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results
Author(s) -
Jordana K. Schmier
Publication year - 2010
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s10486
Subject(s) - bimatoprost , travoprost , latanoprost , medicine , benzalkonium chloride , prostaglandin analogue , prostaglandin , glaucoma , population , eyelash , expert opinion , ophthalmology , intensive care medicine , environmental health , pathology , genetics , biology
To estimate first-year treatment costs among new initiators of topical prostaglandin analogs in a managed care population.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom